Inhibrx Biosciences Inc (INBX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inhibrx Biosciences Inc   (NASDAQ: INBX)


Inhibrx Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Inhibrx Biosciences Inc's ROI in the second quarter of 2026?
Inhibrx Biosciences Inc recorded a cumulative net loss of $-138 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -102.78%.

Within the Healthcare sector 396 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3303 to 3955.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -22.14 % -20.64 % -16.93 % -24.38 % -32.37 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 126 157 113 141 173
Return On Investment (TTM) -102.78 % -89.05 % -89.44 % -94.9 % -94.8 %
INBX's Overall Ranking # 3955 # 3303 # 3143 # 3531 # 3272
Seq. Investment Change TTM -8.04 % -6.63 % -4.19 % -5.35 % -6.27 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -138 -130 -140 -155 -164

INBX Company Profile >> Back to INBX Roi Comparisons >> See Annual INBX Return On Investment



Return On Investment INBX's Ranking
Within: No.
Industry # 64
Sector # 397
Overall # 3955

Return On Investment Statistics
High Average Low
935.29 %
72.69 %
-109.88 %
(Mar 31 2025)   (Mar 31 2024)







Financial Statements
Inhibrx Biosciences Inc's II. Quarter Investments $ 126 Millions INBX's Balance sheet
Inhibrx Biosciences Inc's II. Quarter Income $ -37 Millions Quarterly INBX's Income Statement
INBX's Income by Division See INBX's Income by Division


INBX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 113 140 250 260 123
Y / Y Investment Growth -19.54 % -44.09 % -3.71 % 111.74 % 9.36 %
Net Income in Millions -140 1,688 -241 -145 -82
Y / Y Net Income Growth - - - - -
Annual Return On Investment -124.3 % 1205.09 % -96.36 % -55.83 % -66.56 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INBX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INBX's Competitors
Subscribers only: Roi for Inhibrx Biosciences Inc's Suppliers
Subscribers only: Return On Investment for INBX's Customers

Other Ratios
INBX's Roa INBX's Inventory Turnover Ratio INBX's Growth Rates INBX's Dividend Statistics
INBX's Profitability Ratios INBX's Asset Turnover Ratio INBX's Dividend Growth
INBX's Roe INBX's Valuation Ratios INBX's Financial Strength Ratios INBX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:43:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.